The small molecules WZB117 and STF-31, which act as the inhibitors of GLUT1, could also suppress the tumor growth in cell lines and animal experiments while exerting a synergism with the chemotherapeutics such as Cisplatin or Paclitaxel [64,65]. The gene discussed is SLC2A1; the disease is neoplasm.